Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Michl

Showing results (91-100 of 151) with videos related to

Pageof 16
Sort By:
United European Gastroenterology Journal|September 20, 2025
Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in EuropeAfrodita Panaitescu-Damian, Ibrahim Gürcinar, Viorelia Stoica, et al.
Gut|December 20, 2014
Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulationBarbara Behm, Pietro Di Fazio, Patrick Michl, et al.
Oncoimmunology|July 30, 2016
miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancerLeonie Mühlberg, Benjamin Kühnemuth, Eithne Costello, et al.
United European Gastroenterology Journal|November 21, 2023
Body composition parameters predict survival in pancreatic cancer-A retrospective multicenter analysisMarko Damm, Ljupcho Efremov, Mustafa Jalal, et al.
Neoplasia (New York, N.Y.)|January 10, 2014
Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancerNada Milosevic, Benjamin Kühnemuth, Leonie Mühlberg, et al.
Zeitschrift Fur Gastroenterologie|April 12, 2023
[Climate Crisis: What Gastrointestinal Complications of this Medical Emergency Should We Be Aware Of?]Jens Walldorf, Nikolaus Christian Simon Mezger, Lena Weber, et al.
Cancer Cell|June 14, 2005
CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasivenessPatrick Michl, Antoine R Ramjaun, Olivier E Pardo, et al.
Nucleic Acids Research|August 8, 2020
The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancerSimon Müller, Nadine Bley, Bianca Busch, et al.
United European Gastroenterology Journal|April 9, 2025
The Growing Burden of Obesity: Addressing a Global Public Health ChallengePatrizia Burra, Elvira Verduci, Jorge Amil Dias, et al.
Journal of Cancer Research and Clinical Oncology|January 26, 2023
Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional surveySabine Sommerlatte, Celine Lugnier, Olaf Schoffer, et al.
Pageof 16

Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
United European Gastroenterology Journal|September 20, 2025
Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in EuropeAfrodita Panaitescu-Damian, Ibrahim Gürcinar, Viorelia Stoica, et al.
Gut|December 20, 2014
Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulationBarbara Behm, Pietro Di Fazio, Patrick Michl, et al.
Oncoimmunology|July 30, 2016
miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancerLeonie Mühlberg, Benjamin Kühnemuth, Eithne Costello, et al.
United European Gastroenterology Journal|November 21, 2023
Body composition parameters predict survival in pancreatic cancer-A retrospective multicenter analysisMarko Damm, Ljupcho Efremov, Mustafa Jalal, et al.
Neoplasia (New York, N.Y.)|January 10, 2014
Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancerNada Milosevic, Benjamin Kühnemuth, Leonie Mühlberg, et al.
Zeitschrift Fur Gastroenterologie|April 12, 2023
[Climate Crisis: What Gastrointestinal Complications of this Medical Emergency Should We Be Aware Of?]Jens Walldorf, Nikolaus Christian Simon Mezger, Lena Weber, et al.
Cancer Cell|June 14, 2005
CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasivenessPatrick Michl, Antoine R Ramjaun, Olivier E Pardo, et al.
Nucleic Acids Research|August 8, 2020
The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancerSimon Müller, Nadine Bley, Bianca Busch, et al.
United European Gastroenterology Journal|April 9, 2025
The Growing Burden of Obesity: Addressing a Global Public Health ChallengePatrizia Burra, Elvira Verduci, Jorge Amil Dias, et al.
Journal of Cancer Research and Clinical Oncology|January 26, 2023
Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional surveySabine Sommerlatte, Celine Lugnier, Olaf Schoffer, et al.
Pageof 16